Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2619 with DOI

0 strong · 8 moderate · 18 weak

Compilations

12026-04-25T23:30:51.955Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

46last ruled 2026-05-23

8 awaiting a ruling

Issued documents

42026-10-19T20:29:43.550Z

notice · info card · emergency

Searches

172 with no results

queries and counts on the build

Claims checked

9583 supported

83 supported · 12 not

Correspondence

0received

consent field ships in Phase 4

Edges

288

derivations recorded for this entity

Complete over 26 sources, 1 compilation, and 46 decisions.Not here: the private journal (never); 8 proposals awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/3-meo-pcp/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-24srcQualitative and quantitative in silico toxicity profiling of 'angel dust': phencyclidine (PCP) analogues as new psychoactive substances (3-HO-PCP, 3-MeO-PCP, 4-MeO-PCP, 3-HO-PCE, 3-MeO-PCE, 4-MeO-PCE)
  3. 2026-09-24srcADME profile of phencyclidine (PCP) analogues: emerging dissociative hallucinogens 3-MeO-PCP (CAS: 72242-03-6) and 4-MeO-PCP — a multi-in silico approach
  4. 2026-09-24srcIntoxication by 3-MeO-PCP and O-desmethyltramadol: an unusual NPS mix
  5. 2026-09-24src3-MeO-PCP intoxication in two young men: First in vivo detection in Italy
  6. 2026-09-24srcA non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
  7. 2026-09-24srcThe risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands
  8. 2026-09-24srcAssessment of NMDA receptor inhibition of phencyclidine analogues using a high-throughput drebrin immunocytochemical assay
  9. 2026-09-24srcDetermination of 3-MeO-PCP in human blood and urine in a fatal intoxication case, with a specific focus on metabolites identification
  10. 2026-09-24srcThe First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature
  11. 2026-09-24srcFatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method
  12. 2026-09-24srcTwo Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine
  13. 2026-09-24srcTwo Fatal Intoxications Involving 3-Methoxyphencyclidine
  14. 2026-09-24srcMetabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases
  15. 2026-09-24srcDetectability of Dissociative Psychoactive Substances in Urine by Five Commercial Phencyclidine Immunoassays
  16. 2026-09-24srcIntoxication with 3-MeO-PCP alone: A case report and literature review
  17. 2026-09-24srcThe ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor
  18. 2026-09-24srcNew Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations
  19. 2026-09-24srcAnalytical Characterization of 3-MeO-PCP and 3-MMC in Seized Products and Biosamples
  20. 2026-09-24src3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report
  21. 2026-09-24srcThe Synthesis of Phencyclidine and Other 1-Arylcyclohexylamines
  22. 2026-09-24src3-methoxy PCP (hydrochloride) CAS 91164-58-8 - Product Certificate
  23. 2026-09-24srcErowid 3-MeO-PCP Legal Status
  24. 2026-09-24srcFederal Register: Placement of 3-Methoxyphencyclidine in Schedule I
  25. 2026-09-24srcWHO ECDD Critical Review: 3-Methoxyphencyclidine
  26. 2026-09-24src3-MeO-PCP - Wikipedia
  27. 2026-09-24srcPubChem Compound: 3-methoxyphencyclidine (CID 11778080)
  28. 2026-09-04issueIssued emergency
  29. 2026-09-04issueIssued info_card
  30. 2026-09-04issueIssued notice
  31. 2026-05-23publicationPublication — backfill
  32. 2026-04-25proposalcontraindication · respiratory
  33. 2026-04-25proposalcontraindication · other
  34. 2026-04-25proposalcontraindication · pregnancy_breastfeeding
  35. 2026-04-25proposalcontraindication · hepatic
  36. 2026-04-25proposalcontraindication · psychiatric
  37. 2026-04-25proposalcontraindication · psychiatric
  38. 2026-04-25proposalcontraindication · cardiovascular
  39. 2026-04-25proposalcontraindication · cardiovascular
  40. 2026-04-25proposalcontraindication · cardiovascular
  41. 2026-04-25proposalduration · insufflated · aftereffects
  42. 2026-04-25proposalduration · insufflated · total
  43. 2026-04-25proposalduration · insufflated · offset
  44. 2026-04-25proposalduration · insufflated · peak
  45. 2026-04-25proposalduration · insufflated · come_up
  46. 2026-04-25proposalduration · insufflated · onset
  47. 2026-04-25proposalduration · oral · aftereffects
  48. 2026-04-25proposalduration · oral · total
  49. 2026-04-25proposalduration · oral · offset
  50. 2026-04-25proposalduration · oral · peak
  51. 2026-04-25proposalduration · oral · come_up
  52. 2026-04-25proposalduration · oral · onset
  53. 2026-04-25proposaldosage · insufflated
  54. 2026-04-25proposaldosage · oralworking →
  55. 2026-04-25proposaltolerance
  56. 2026-04-25proposalwithdrawal
  57. 2026-04-25proposaldependence · full
  58. 2026-04-25proposaltoxicity
  59. 2026-04-25proposaltimeline · insufflated · afterglow
  60. 2026-04-25proposaltimeline · insufflated · resolution
  61. 2026-04-25proposaltimeline · insufflated · plateau
  62. 2026-04-25proposaltimeline · insufflated · peak
  63. 2026-04-25proposaltimeline · insufflated · come_up
  64. 2026-04-25proposaltimeline · insufflated · onset
  65. 2026-04-25proposaltimeline · oral · afterglow
  66. 2026-04-25proposaltimeline · oral · resolution
  67. 2026-04-25proposaltimeline · oral · plateau
  68. 2026-04-25proposaltimeline · oral · peak
  69. 2026-04-25proposaltimeline · oral · come_up
  70. 2026-04-25proposaltimeline · oral · onset
  71. 2026-04-25proposaldose_tier · heavy
  72. 2026-04-25proposaldose_tier · strong
  73. 2026-04-25proposaldose_tier · common
  74. 2026-04-25proposaldose_tier · light
  75. 2026-04-25proposaldose_tier · threshold
  76. 2026-04-25revisionRevision 1
  77. 2026-04-25absenceSearched PubMed for "3-MeO-PCP 3-methoxyphencyclidine pharmacology receptor binding" — no results
  78. 2026-04-25absenceSearched PubMed for "3-methoxyphencyclidine manic episode dissociative hallucinogen NPS" — no results
  79. 2026-04-25genGeneration — pipeline-v5 · with 8 morepipeline-v5
  80. 2026-04-25rungeneration run

The same entries, as forms: six forms.